Baxter to buy Sweden's Gambro for about $4 bln

Tue Dec 4, 2012 7:15am EST

Dec 4 (Reuters) - Baxter International Inc said it agreed to buy privately held Swedish dialysis product company Gambro AB for about $4 billion to boost its renal therapies portfolio.

The deal, which is expected to close in the first half of 2013, will be financed through a combination of cash generated from overseas operations and debt.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.